Will the Case of Billy Caldwell Set a New Precedent for Medical Cannabis in the UK?
Source: Pixabay

Will the Case of Billy Caldwell Set a New Precedent for Medical Cannabis in the UK?

According to a story from uk.news.yahoo.com, when Billy Caldwell, age 12, and his mother returned from traveling to Canada, the Home Office initially confiscated a substance that had been the…

Continue Reading Will the Case of Billy Caldwell Set a New Precedent for Medical Cannabis in the UK?

Enrollment Has Been Completed For a Clinical Trial of ARO-AAT, an Investigational Therapy for Alpha-1 Antitrypsin Deficiency

Arrowhead Pharmaceuticals, Inc. have announced that they have completed patient enrollment for a Phase 1 clinical trial investigating ARO-AAT, an investigational therapy for the treatment of a genetic liver disease…

Continue Reading Enrollment Has Been Completed For a Clinical Trial of ARO-AAT, an Investigational Therapy for Alpha-1 Antitrypsin Deficiency
Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Submitted for FDA Approval
jarmoluk / Pixabay

Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Submitted for FDA Approval

According to a story from Business Wire, the company Alexion Pharmaceuticals recently announced that it has submitted a Biologics License Application (BLA) to the FDA for the approval of one…

Continue Reading Possible Treatment for Paroxysmal Nocturnal Hemoglobinuria Submitted for FDA Approval
This New Program Can Help Make Life Easier for Rare Disease Patients
geraldoswald62 / Pixabay

This New Program Can Help Make Life Easier for Rare Disease Patients

According to a story from CheckOrphan, Express Scripts has prepared a Rare Conditions Care Value (RCCV) program. This program is designed to help make the diagnosis and treatment process for…

Continue Reading This New Program Can Help Make Life Easier for Rare Disease Patients
Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced
rawpixel / Pixabay

Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced

Data from a Phase II clinical trial of the experimental treatment reldesemtiv for the treatment of spinal muscular atrophy has been announced. The drug has shown positive effects in the…

Continue Reading Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced

Interim Data From a Study of a Sickle Cell Disease Gene Therapy Has Been Announced

The experimental gene therapy LentiGlobin for the treatment of severe sickle cell disease is being investigated in an ongoing Phase 1 clinical trial. Bluebird Bio, the company developing the therapy,…

Continue Reading Interim Data From a Study of a Sickle Cell Disease Gene Therapy Has Been Announced
Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa
rawpixel / Pixabay

Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa

According to a story from pm360online.com, the drug development company ProQR Therapeutics N.V. will be partnering with EB Research Partnership (EBRP) and EB Medical Research Foundation (EBMRF) in order to…

Continue Reading Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa
Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches
https://pixabay.com/en/father-daughter-beach-family-daddy-656734/

Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches

According to a story from CBS News, Clay Emerson, from New Jersey, is hoping to use Father's Day in order to raise awareness about his three year old daughter's rare…

Continue Reading Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches

Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation

According to a story from pm360online.com, the speciality pharmaceutical company Chiesi USA and the biotech company Holostem Terapie Avanzate S.r.l. of Italy recently announced that the U.S. FDA recently granted orphan…

Continue Reading Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation

A Nigerian Mother Writes Heart-Melting Eulogy for Deceased Daughter Who Died of Hodgkin Lymphoma

A Nigerian mother, Hafsat Aliyu has penned a moving tribute to her beautiful daughter, Zainab, who died of Hodgkin lymphoma, a type of blood cancer, on May 7, 2015. She…

Continue Reading A Nigerian Mother Writes Heart-Melting Eulogy for Deceased Daughter Who Died of Hodgkin Lymphoma